Bibliography
Found 55 results
Filters: Keyword is Cohort Studies [Clear All Filters]
The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts. Journal of Clinical and Experimental Neuropsychology [Internet]. 2007 ;29:669-78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17691040
. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. The Journal of Infectious Diseases [Internet]. 2008 ;197:597-607. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18275278
. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Archives of Neurology [Internet]. 2008 ;65:1096-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18695060
. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology. 2009 ;73(23):1982-7.
. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2009 ;51:569-573. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19521250
. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney International [Internet]. 2009 ;75:428-434. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19052538
. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.
Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011 ;33(5):505-22.
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012 ;18(1):79-88.
Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics. 2012 ;53(4):380-6.
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 ;78(7):485-92.
Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014 ;20(6):603-11.
Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014 ;28(11):1579-91.
. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.
. Effects of information processing speed on learning, memory, and executive functioning in people living with HIV/AIDS. J Clin Exp Neuropsychol. 2014 ;36(8):806-17.
. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
. HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 ;28(9):1297-306.
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment. J Acquir Immune Defic Syndr. 2014 ;65(2):190-7.
. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 ;68(3):281-8.
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.